α-Lipoic acid modulates liver fibrosis: a cross talk between TGF-β1, autophagy, and apoptosis
WH El-Maadawy, OA Hammam… - Human & …, 2020 - journals.sagepub.com
Autophagy and apoptosis are important players in the progression of hepatic fibrosis via
activation of hepatic stellate cells (HSCs). Despite the recently depicted antifibrotic effects of …
activation of hepatic stellate cells (HSCs). Despite the recently depicted antifibrotic effects of …
α-Lipoic acid inhibits liver fibrosis through the attenuation of ROS-triggered signaling in hepatic stellate cells activated by PDGF and TGF-β
Reactive oxygen species (ROS) have been implicated in hepatic stellate cell activation and
liver fibrosis. We previously reported that α-lipoic acid (LA) and its reduced form …
liver fibrosis. We previously reported that α-lipoic acid (LA) and its reduced form …
[HTML][HTML] α‑lipoic acid protects against carbon tetrachloride‑induced liver cirrhosis through the suppression of the TGF‑β/Smad3 pathway and autophagy
G Liu, J Liu, L Pian, S Gui, B Lu - Molecular Medicine …, 2019 - spandidos-publications.com
Abstract α‑lipoic acid (ALA) is a naturally occurring antioxidant with protective effects against
various hepatic injuries. The aim of the present study was to investigate the mechanisms by …
various hepatic injuries. The aim of the present study was to investigate the mechanisms by …
[HTML][HTML] Salvianolic acid B inhibits autophagy and activation of hepatic stellate cells induced by TGF-β1 by downregulating the MAPK pathway
N Jiang, J Zhang, J Ping, L Xu - Frontiers in Pharmacology, 2022 - frontiersin.org
In liver fibrosis, transforming growth factor-β1 (TGF-β1) can stimulate autophagy and
activation of hepatic stellate cells (HSCs). Autophagy, playing a crucial role in HSCs …
activation of hepatic stellate cells (HSCs). Autophagy, playing a crucial role in HSCs …
Synergistic effect of natural compounds on the fatty acid-induced autophagy of activated hepatic stellate cells
KW Lee, V Thiyagarajan, HW Sie, MF Cheng… - The Journal of …, 2014 - Elsevier
Autophagy, a lysosomal pathway to maintain cellular homeostasis, is mediated via the
mammalian target of rapamycin (mTOR)-dependent pathways. Hepatic stellate cells (HSCs) …
mammalian target of rapamycin (mTOR)-dependent pathways. Hepatic stellate cells (HSCs) …
Palmitic acid elicits hepatic stellate cell activation through inflammasomes and hedgehog signaling
Aims Activation of hepatic stellate cells (HSCs) plays a pivotal role at the center of the
fibrogenic progression in nonalcoholic steatohepatitis (NASH). However, it is poorly …
fibrogenic progression in nonalcoholic steatohepatitis (NASH). However, it is poorly …
Oleic acid improves hepatic lipotoxicity injury by alleviating autophagy dysfunction
X Liu, X Li, S Su, Y Yuan, W Liu, M Zhu, Q Zheng… - Experimental Cell …, 2023 - Elsevier
Lipotoxicity caused by excess free fatty acids, particularly saturated fatty acids (SFAs) such
as palmitic acid (PA), is one of the most important pathogenesis of nonalcoholic fatty liver …
as palmitic acid (PA), is one of the most important pathogenesis of nonalcoholic fatty liver …
Molecular hepatoprotective effects of lipoic acid against carbon tetrachloride-induced liver fibrosis in rats: Hepatoprotection at molecular level
Background: Liver fibrosis is a noteworthy well-being issue that can prompt the progression
of liver cirrhosis and hepatocellular carcinoma. Prominently, many antioxidants have been …
of liver cirrhosis and hepatocellular carcinoma. Prominently, many antioxidants have been …
[HTML][HTML] 3-Methyladenine ameliorates liver fibrosis through autophagy regulated by the NF-κB signaling pathways on hepatic stellate cell
B Wang, H Yang, Y Fan, Y Yang, W Cao, Y Jia, Y Cao… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Methyladenine (3-MA) is a selective type III phosphatidylinositol 3-kinase (PI3K) inhibitor
and also blocks autophagosome formation. However, the effect of 3-MA in liver fibrosis has …
and also blocks autophagosome formation. However, the effect of 3-MA in liver fibrosis has …
[HTML][HTML] α-Lipoic acid protects against cyclosporine a-induced hepatic toxicity in rats: effect on oxidative stress, inflammation, and apoptosis
EM El-Mancy, DMA Elsherbini, RH Al-Serwi… - Toxics, 2022 - mdpi.com
The clinical application of cyclosporine A (CsA) as an immunosuppressive agent is limited
by its organ toxicity. We aimed to evaluate the effectiveness of α-lipoic acid against CsA …
by its organ toxicity. We aimed to evaluate the effectiveness of α-lipoic acid against CsA …